Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared an update from Novartis, on LinkedIn, adding:
“This sentence jumped out at me:
‘Novartis was built by people who were willing to do things nobody had done before’.
I have witnessed this to be true and fully agree with Vas Narasimhan. For more than 25 years, The Max Foundation has partnered with Novartis because we share a core belief: geography should not determine destiny. I have been witness to the commitment and unwavering support of every individual working at the company, and I have seen what is possible when science and compassion come together in the service of patients, especially those most in need.
Not for one minuted I have taken for granted the trust, as twice in the past two decades we embarked together to do something that had never been done before: creating systems in service of people where these systems did not exist.
I hope these efforts encourage others in the industry to lead with courage and create deeper impact on the lives of thousands more families in the years ahead.”
Quoting Novartis:
“Thirty years ago today, the European Commission approved the merger that would lead to the creation of Novartis. It was the start of a new company, built on more than 250 years of science, discovery, and people willing to try what had never been done before. Since then, that foundation has helped turn ideas once considered out of reach into realities for patients.
As we mark 30 years, we’re looking ahead to the next questions science can help answer – and the patients who are still waiting for necessary treatments.”
Other articles about The Max Foundation on OncoDaily.